Biomarin Pharmaceutical (BMRN)'s 30-day implied volatility (IV30) was 35.5% at the close on November 18, 2026, up from 35.2% the day before, against a 52-week range of 19.3% to 55.5%. Its 20-day historical volatility was 30.1%.
Data as of November 18, 2026.